Actinogen Medical Ltd (ACWOD) Key Financial Indicators

0.026
0.0000.00%

20min DelayTrading Jan 15 15:40 AET

82.86MMarket Cap0.00P/E (Static)

ACWOD Free Cash Flow (FCF)

Interested in knowing about Actinogen Medical Ltd's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: AUD

Cumulative Quarterly

ACWOD Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Actinogen Medical Ltd shows that the company's current ratio is 3.76, indicating healthy liquidity.

Currency: AUD

Cumulative Quarterly

ACWOD Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Actinogen Medical Ltd, the quick ratio is 3.74, indicating that the company can meet its short-term debt obligations.

Currency: AUD

Cumulative Quarterly

ACWOD Return on Equity (ROE)

Want to learn more about the financial health of Actinogen Medical Ltd? The latest ROE figure is --, indicating that the company has stable profitability.

Currency: AUD

Cumulative Quarterly

ACWOD Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Actinogen Medical Ltd, the total asset return on investment (ROA) is --.

Currency: AUD

Cumulative Quarterly

ACWOD Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Actinogen Medical Ltd's latest financial report to see how their gross margin is doing - currently at --.

Currency: AUD

Cumulative Quarterly

ACWOD Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Actinogen Medical Ltd, the net profit margin is --, which is a good sign for its profitability.

Currency: AUD

Cumulative Quarterly

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"